Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Salestools Logo

Salestools

The #1 AI Agent for Sales teams and Go To Market teams. Sell more, faster, with less effort.

Product

  • AI Sales Agents
  • Intent Data
  • Technology Data
  • Visitor Tracking
  • Co-Pilot
  • Social Selling

Solutions

  • Customer Service
  • E-commerce
  • SaaS
  • Enterprise
  • Small Business

Resources

  • The Report
  • Documentation
  • API Reference
  • Help Center
  • Blog
  • Case Studies
  • Webinars

Company

  • About
  • Careers
  • Press
  • Contact
  • Partners

Our locations

  • New York, HQ
  • Bucharest, AI Research Lab
  • Zug, Switzerland

Β© 2026 Salestools. All rights reserved.

Data Terms & SecurityPrivacy PolicyTerms of ServiceAcceptable Use
All systems operational
Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Back to Reports
Biotech

Retro Biosciences

Retro Biosciences raises $1B Growth at $2B valuation

San Mateo, CAJanuary 22, 20251 min read
Total Raised
$1B
Valuation
$2B
Latest Round
Growth
Employees
150+

Retro Biosciences: Growth Funding Round

Retro Biosciences has successfully raised $1B in Growth funding, reaching a valuation of $2B.

Company Overview

Extending healthy human lifespan

Funding Details

The Growth round was led by Sandro Salsano, with participation from Y Combinator.

Company Information

  • Headquarters: San Mateo, CA
  • Founded: 2021
  • Employees: 150+
  • Category: Biotech

Investment

Retro Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • Sandro Salsano: Verified investor in Growth
  • Y Combinator: Verified investor in Growth

Company Info

Headquarters
San Mateo, CA
Founded
2021
Team Size
150+
Last Round
$1B(Jan 2025)

Investors (2)

S
Sandro SalsanoLead
Lead Investor
Verified investor in Growth
Y
Y Combinator
Investor
Verified investor in Growth

Topics

verified(3079)real-funding(3079)retro-biosciencesbiotechgrowthsan-mateo

Share

Related Reports

Biotech
AusperBio

AusperBio Raises $73M Series B

Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials

David Chen
David Chen
Dec 30, 2025
0 min readβ€’$73M Series B
Biotech
Orna Therapeutics

Orna Therapeutics Raises $251M Series B

Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases

Emma Rodriguez
Emma Rodriguez
Oct 23, 2025
0 min readβ€’$251M Series B
Biotech
Forge Biologics

Forge Biologics Raises $120M Series C

Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines

Sarah Kim
Sarah Kim
Oct 23, 2025
0 min readβ€’$120M Series C

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free